1319207-44-7 | CC0651 (Catalog# : 611933)CC0651 is an allosteric inhibitor of the human cdc34 ubiquitin-conjugating enzyme that potently (IC50 = 1.72 uM) inhibited the ubiquitination of p27 Kip1. CC0651 that potently
1421693-22-2 | CDKI-73 (Catalog# : 611920)CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM; shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM). CDKI-73 was cyt
1431697-74-3 | CAL-130 (Catalog# : 611822)CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that combined inhibition of PI3K/ as therapy for T cell acute lymphoblastic leukemia (T-ALL).
163042-96-4 | CF-102 (Catalog# : 16053104)CF-102, also known as 2-Cl-IB-MECA, is an orally bioavailable, synthetic, highly selective adenosine A3 receptor (A3AR) agonist with potential antineoplastic activity. Adenosine
1446144-04-2 | CPI-203 (Catalog# : 030201)CPI 203 is a novel potent, selective and cell permeable inhibitor of the bromodomain and extra terminal (BET) family protein BRD4 with an IC50 of ~37 nM (BRD4 -screen assay).
1542705-92-9 | CB-5083 (Catalog# : 012002)CB-5083 is a novel first in class, potent orally bio-available p97 inhibitor that disrupts cellular protein homeostasis and demonstrates anti-tumor activity in solid and hematolo